Originally published January 31 2006
The promise of gene therapies may take years to be fully realized
by Mike Adams, the Health Ranger, NaturalNews Editor
Leading scientists like Gu Jianren of the Shanghai Institute of Cancer have caught the world's attention with their studies and innovations in the field of gene therapy, but the impact of these findings may not be felt by diseased patients for many years.
Despite the exciting prospects of treating cancer patients with gene therapy techniques, many challenges remain, according to leading scientists.
Early this year, a study published in London-based magazine Nature indicated that inserting p53 genes into rats quickens the onset of ageing and weakens their general physical condition.
Although an adenovirus used as a vector to weaken and even kill cancerous cells has been found to produce limited side effects in humans, such as fever, some say the side effects may be serious for late-stage cancer patients.
Other scientists worry the virus vector could prompt the body's own antibodies to kill the virus itself and stop it from entering target cells.
More serious but untested worries include concern about the conveyed therapeutic gene, or other genes of the virus vector, may integrate with the human genome to lead to unexpected gene mutations causing cancers and other diseases.
Lu Youyong of the School of Oncology, Peking University, and a leading scientist behind Gendicine research, said the injection of the gene into tumour cells prevents the natural antibody reactions of the human body.
"As for the effect of the p53 gene in weakening the human body itself, we must balance this effect with the therapeutic role against cancer," Lu said.
Fang Bingliang, an associate professor at the University of Texas MD Anderson Cancer Centre in the United States, has tried another approach to gene therapy.
According to Fang, in typical gene therapies, scientists deliver certain genes to human cells, or deliver oncolytic viruses to eliminate human cells containing certain genes that are dysfunctional.
These approaches all involve the use of very big molecules or big molecule-based viruses as drugs, which cannot move everywhere in the human body.
"This combines the advantage of traditional chemical method, such as all-body dosage, low costs and no antibody reaction, and the novel gene studies.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml